LEADER 02046nam  2200601Ia 450 
001 9910452142703321
005 20200520144314.0
010   $a1-280-70492-6
010   $a9786610704927
010   $a0-309-65814-4
035   $a(CKB)1000000000469281
035   $a(OCoLC)560385115
035   $a(CaPaEBR)ebrary10150106
035   $a(SSID)ssj0000137700
035   $a(PQKBManifestationID)11130061
035   $a(PQKBTitleCode)TC0000137700
035   $a(PQKBWorkID)10088698
035   $a(PQKB)11501473
035   $a(MiAaPQ)EBC3378153
035   $a(Au-PeEL)EBL3378153
035   $a(CaPaEBR)ebr10150106
035   $a(CaONFJC)MIL70492
035   $a(OCoLC)923277128
035   $a(EXLCZ)991000000000469281
100   $a20060807d2006      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aDeveloping biomarker-based tools for cancer screening, diagnosis, and treatment$b[electronic resource] $ethe state of the science, evaluation, implementation, and economics /$fMargie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum
210   $aWashington, DC $cNational Academies Press$dc2006
215   $a1 online resource (112 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-10134-4 
320   $aIncludes bibliographical references.
606   $aTumor markers$vCongresses
606   $aBiochemical markers$vCongresses
608   $aElectronic books.
615  0$aTumor markers
615  0$aBiochemical markers
676   $a616.99/4075
700   $aPatlak$b Margie$0870815
701   $aNass$b Sharyl J$0857626
712 02$aNational Cancer Policy Forum (U.S.)
712 02$aUnited States.$bDept. of Health and Human Services.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910452142703321
996   $aDeveloping biomarker-based tools for cancer screening, diagnosis, and treatment$92442698
997   $aUNINA